Abstract
Background
A 26-year-old male had a history of frequent bowel movements, mushy stool with mucus and loss of 25 kg body weight in 6 months was diagnosed as a case of inflammatory bowel disease (IBD). The patient did not respond to routine and standard treatment for IBD. His condition was steadily deteriorating, and he was in a very precarious state when he reported to us.
Methods
Upon laboratory investigation by using IS900 specific PCR [which is specific for Mycobacterium avium subspecies paratuberculosis (MAP)], the blood and stool samples were found negative. However, the presence of low titer MAP-antibodies by indigenous ELISA were found followed by detection of the typical acid-fast MAP bacilli (with 3 + or 4 + grade) microscopically. The MAP stool culture was positive after 6 months incubation. The biotyping by IS1311 specific polymerase chain reaction restriction enzyme (PCR-RE) confirmed infection with ‘Indian Bison Type Genotype’, a dominant biotype infecting the domestic livestock population of India. Standard anti-MAP therapy was initiated under supervision of the treating physician. The drug of choice in prescribed treatment regimen included Isoniazid (5 mg/kg), Rifampicin (10 mg/kg), Ethambutol (15–25 mg/kg) once a day for 24 weeks and Clarithromycin (250 mg)/Levofloxacin (250 mg) twice a day for 6 weeks.
Results
Following treatment, the patient started improving progressively with reduction in bowel movement frequency and gained body weight with an enhanced appetite propensity. Upon follow-up of the patient after 1 year of treatment, stool-microscopy and stool-culture were found negative for MAP. Till the recent past, the patient was further monitored for disease relapse, if any.
Conclusions
This patient has experienced a complete resolution of IBD using a combination of anti-MAP antibiotics. The initial detection of heavy shedding of acid-fast MAP bacilli and typical colony morphology with its characterization obtained from culturing of stool sample indicated the infection of MAP. Interestingly, the present case is one more example of the linkage of demonstrable MAP infection treated with anti-MAP therapy in the presence and then absence of disease in the human host.
References
Bhat AM, Malik HU, Chaubey KK et al (2021) Bio-typing of Mycobacterium avium subspecies paratuberculosis isolates recovered from the Himalayan sheep and goats. Trop Anim Health Prod 53:1–9
Singh PK, Singh SV, Kumar H et al (2010) Diagnostic application of IS900 PCR using blood as a source sample for the detection of Mycobacterium avium subspecies paratuberculosis in early and subclinical cases of caprine paratuberculosis. Vet Med Int 2010:1
Singh SV, Kumar N, Sohal JS et al (2014) First mass screening of the human population to estimate the bio-load of Mycobacterium avium subspecies paratuberculosis in North India. J Biol Sci 14(4):237–247
Singh SV, Singh AV, Singh PK et al (2011) Molecular identification and characterization of Mycobacterium avium subspecies paratuberculosis in free living non-human primate (Rhesus macaques) from North India. Comp Immunol Microbiol Infect Dis 34:267–271
Rawat KD, Chaudhary S, Gupta S et al (2014) Potential of ‘goat-based vaccine’ using ‘India bison biotype’ of Mycobacterium avium subspecies paratuberculosis in salvaging a dairy farm consisting of high yielding Holstein Fresian cows from devastation and closure due to outbreak of bovine Johne’s disease in Northern India. Adv Anim Vet Sci 2:638–646
Chaubey KK, Singh SV, Gupta S, Singh M, Sohal JS, Kumar N, Singh MK, Bhatia AK, Dhama K (2017) Mycobacterium avium subspecies paratuberculosis—an important food borne pathogen of high public health significance with special reference to India: an update. Vet Q 37:282–299
Kuenstner JT, Naser SA, Chamberlin W et al (2017) The consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) conference 2017. Front Public Health 5:1–4
Chaubey KK, Singh SV, Singh PK et al (2020) Detection of anti-Mycobacterium avium subspecies paratuberculosis antibodies in thyroid and type-1 diabetes patients. Indian J Biotechnol 19:49–52
Sechi LA, Dow CT (2015) Mycobacterium avium subsp. paratuberculosis Zoonosis—the hundred year war—beyond Crohn’s Disease. Front Immunol 6:96
Singh SV, Kuenstner JT, Davis WC et al (2016) Concurrent resolution of chronic diarrhea likely due to Crohn’s disease and infection with Mycobacterium avium paratuberculosis. Front Med 3:49
Bandopadhaya S (2012) Crohn’s disease: the indian perspective. Medicine Update 22:419–425. http://www.apiindia.org/pdf/medicine_update_2012/gastroenterology_01.pdf
Probert CS, Mayberry JF et al (1990) Inflammatory bowel disease in the rural Indian subcontinent: a survey of patients attending mission hospitals. Digestion 47:42–46
Loftus EV Jr, Silverstein MD, Sandborn WJ et al (1998) Crohnʹs disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 114(6):1161–1168
Kappelman MD, Moore KR, Allen JK et al (2013) Recent trends in the prevalence of Crohnʹs disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58(2):519–525
Hulten K, Almashhrawi A, El-Zaatari F et al (2000) Antibacterial therapy for Crohnʹs disease: a review emphasizing therapy directed against mycobacteria. Dig Dis Sci 45:445–456
Schultz M, Rieder H, Hersh T et al (1987) Remission of Crohn’s disease with antibacterial chemotherapy. Lancet 330:1391–1392
Agrawal G, Clancy A, Sharma R, Huynh R, Ramrakha S, Borody T (2020) Targeted combination antibiotic therapy induces remission in treatment-naive Crohn’s disease: a case series. Microorganisms 8(3):371
Borody TJ, Leis S, Warren EF, Surace R (2002) Treatment of severe Crohn’s disease using antimycobacterial triple therapy-approaching a cure? Dig Liver Dis 34:29–38
Shafran PC (1999) Treatment of Crohn’s Disease with rifabutin and macrolide antibiotics. Am J Gastroenterol 94:2761
Singh AV, Chauhan DS, Singh SV, Kumar V, Singh A, Yadav A, Yadav VS (2016) Current status of Mycobacterium avium subspecies paratuberculosis infection in animals & humans in India: what needs to be done? Indian J Med Res 144:661–671
Kuenstner JT, Chamberlin W, Naser SA et al (2015) Resolution of Crohn’s disease and complex regional pain syndrome following treatment of paratuberculosis. World J Gastroenterol 21(13):4048–4062
Singh SV, Singh AV, Singh PK et al (2007) Evaluation of an indigenous ELISA for diagnosis of Johne’s disease and its comparison with commercial kits. Indian J Microbiol 47:251–258
Collins MT (2002) Interpretation of a commercial bovine paratuberculosis enzyme-linked immunosorbent assay by using likelihood ratios. Clin Diagn Lab Immunol 9(6):1367–1371
Parashar D, Kabra SK, Lodha R, Delhi Pediatric TB Study Group et al (2013) Does neutralization of gastric aspirates from children with suspected intrathoracic tuberculosis affect mycobacterial yields on MGIT culture? J Clin Microbiol 51:1753–1756
Whipple DL, Callihan DR, Jarnagin JL (1991) Cultivation of Mycobacterium paratuberculosis from bovine fecal specimens and a suggested standardized procedure. J Vet Diagn Invest 3:368–373
Singh SV, Gupta S, Singh PK et al (2013) Therapeutic management of clinical Bovine Johne’s disease using goat based ‘indigenous vaccine’ in native Hariana Cattle: case reports. Adv Anim Vet Sci 1(1S):23–28
Gupta S, Singh SV, Singh M et al (2019) Vaccine approaches for the ‘therapeutic management’ of Mycobacterium avium subspecies paratuberculosis infection in domestic livestock. Vet Q 39:143–152
Shankar H, Singh SV, Singh PK et al (2010) Presence, characterization, and genotype profiles of Mycobacterium avium subspecies paratuberculosis from unpasteurized individual and pooled milk, commercial pasteurized milk, and milk products in India by culture, PCR, and PCR_REA methods. Int J Infect Dis 14:121–126
Singh M, Gupta S, Chaubey KK et al (2020) Bio-safety of milk products and mycobacterium avium subspecies paratuberculosis as major microbial contaminant using multiple tests including culture and SYBR green real-time assay. J Exp Biol Agric Sci 8:508–523
Singh SV, Singh PK, Singh AV et al (2014) Bio-load and bio-type profiles of Mycobacterium avium subspecies paratuberculosis infection in the farm and farmer’s herds/flocks of domestic livestock: a 28 years study (1985–2013). Transbound Emerg Dis 61(Suppl. 1):43–55
Sohal JS, Sheoran N, Narayansamy K et al (2009) Genomic analysis of local isolate of Mycobacterium avium subspecies paratuberculosis. Vet Microbiol 134:375–382
Tuci A, Tonon F, Castellani L et al (2011) Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohnʹs disease and ulcerative colitis patients and healthy subjects. Dig Dis Sci 56:2957–2962
Das K, Ghoshal UC, Dhali GK et al (2009) Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci 54:1099–1107
Greenstein RJ, Su L, Shahidi A, Brown ST (2007) On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS ONE 2(6):e516
Kochhar R, Gupta V, Dutta U et al (2011) Infliximab induced endophthalmitis in a patient of fistulizing Crohn’s disease. Indian J Gastroenterol 30(5):241–242
Acknowledgements
Authors are thankful to ICAR, New Delhi for providing the funds and Director, Central Institute for Research on Goats (CIRG), Mathura, India for providing necessary facilities. We acknowledge Dr. Anil K. Verma, Celiac Disease Research Laboratory, Università Politecnica delle Marche Via Toti 11, Ancona, Italy for critical reading and editing of this manuscript.
Funding
This work is supported by the Indian Council of Agricultural Research, New Delhi, India (Outreach Program on Zoonotic Diseases, Grant File Number: 2-1/OPZD/VPH/2015-16/127) and project was ethically approved by the Institutional Ethics Committee (IEC) of IVRI (Division of Vet. Public Health), Izzatnagar (Bareilly), UP for 14 collaborating centers.
Author information
Authors and Affiliations
Contributions
SG carried out all the experiments, prepared figures and drafted the manuscript. KKC collected the data and analysis. PA senior physician designed the drug regiment/therapeutics, JTK and DP participated in data analysis and interpretation of results. SG, DP and SVG design the study, participated in data analysis, and drafted the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare there were no financial or commercial conflict of interest associated with the report of the present study.
Informed consent
Written informed consent was obtained from the patient for treatment and for publication of this report and accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gupta, S., Chaubey, K.K., Agarwal, P. et al. Therapeutic management of Mycobacterium avium subspecies paratuberculosis infection with complete resolution of symptoms and disease in a patient with advanced inflammatory bowel syndrome. Mol Biol Rep 48, 7013–7020 (2021). https://doi.org/10.1007/s11033-021-06615-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06615-3